Dr. Codrin Lungu previously served as Program Director in the Division of Clinical Research at National Institute of Health (NIH). He is a board-certified neurologist, specializing in movement disorders, and has additional training in research methodology, clinical trial design, deep brain stimulation mechanisms, and management and neurotoxin therapy. Dr. Lungu established the first NIH Deep Brain Stimulation (DBS) program, and led the NIH Botulinum Toxin clinic, and conducted collaborative research in several areas related to movement disorders. While at NIH, He led research programs for, among others, imaging biomarkers in Parkinson’s disease, objective diagnostic and assessment measures, and therapeutic clinical trials. Dr. Lungu also co-directed the NIH Movement Disorders fellowship and was the principal investigator on research projects involving multimodal diagnostic studies, novel applications of DBS therapy and clinical trials of experimental agents. He currently serves as Clinical Development Lead, Neuroscience with Bristol Myers Squibb.
